ZNF568 is a zinc finger transcription factor that functions as a repressor of gene expression through both TRIM28-dependent and independent mechanisms 1. During embryonic development, ZNF568 directly represses placental-specific IGF2 transcripts and regulates convergent extension movements essential for axis elongation and tissue morphogenesis 2. The protein binds sequence-specific DNA elements through its eleven-zinc finger array, with individual zinc fingers recognizing 2-4 bases in an adaptable manner that accommodates DNA conformation variations 2. ZNF568 is also critical for maintaining neural stem cell populations and regulating brain size, with human-specific genetic variants associated with head size variation 3. The gene has rapidly evolved in the human lineage, with enriched expression in fetal brain tissue 3. Functionally, ZNF568 interacts with p53 to regulate mitochondrial oxidative phosphorylation by controlling SCO2 transcription, influencing the balance between glycolysis and mitochondrial respiration 1. Clinically, ZNF568 has emerged as a potential prognostic biomarker in gastric cancer, where elevated expression is associated with increased mortality 4. Additionally, ZNF568 genetic polymorphisms have been identified as modulators of opioid-induced nausea and vomiting in cancer patients 5, and methylation abnormalities have been observed in colorectal cancer development 6.